| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1721d75f5bf603447ec5a26b5c1c0be0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0d0446a5bd77c7da68216fc2e3f05d48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fe58b8698ba286d011e3d0bf70dcc0fa |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-00034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-00021
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-00022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2720-00034 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-701
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70 |
| filingDate |
2018-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62449e41cec9241d82a7cabad764a63e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be44b87571fac14de58e1083116a7f6d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6681f326a92efdc5dc3d2dde065afbb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_123d6c57111003d580bf10ef18176d5e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c7f6dd321878281c62d793e8c18c965 |
| publicationDate |
2018-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2018369360-A1 |
| titleOfInvention |
Novel tilapia virus and uses thereof |
| abstract |
The invention is directed to isolated Tilapia Lake Virus or TiLV, and isolated nucleic acids sequences and polypeptides thereof. The invention also relates to probes and primers, and to antibodies against antigens from TiLV, and use of these reagents for detecting the presence or absence of TiLV in an animal. The invention also relates to iRNAs which target nucleic acid sequences of TiLV. The invention is also related to immunogenic compositions, including antibodies and vaccines, for inducing an immune response against TiLV in an animal. The invention is also related to gene constructs and cells comprising TiLV and isolated nucleic acids sequences and polypeptides thereof for use in developing prophylactic and therapeutic agents. |
| priorityDate |
2014-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |